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Abstract
This study included 168 and 85 mother–infant dyads from Asian and United States of America cohorts to examine whether
a genomic profile risk score for major depressive disorder (GPRSMDD) moderates the association between antenatal maternal
depressive symptoms (or socio-economic status, SES) and fetal neurodevelopment, and to identify candidate biological
processes underlying such association. Both cohorts showed a significant interaction between antenatal maternal
depressive symptoms and infant GPRSMDD on the right amygdala volume. The Asian cohort also showed such interaction on
the right hippocampal volume and shape, thickness of the orbitofrontal and ventromedial prefrontal cortex. Likewise, a
significant interaction between SES and infant GPRSMDD was on the right amygdala and hippocampal volumes and shapes.
After controlling for each other, the interaction effect of antenatal maternal depressive symptoms and GPRSMDD was mainly
© The Author 2017. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/article-abstract/27/5/3080/3074416 by U
niversity of N
orth C
arolina at C
hapel H
ill - H
ealth Sciences Library user on 13 August 2019
shown on the right amygdala, while the interaction effect of SES and GPRSMDD was mainly shown on the right
hippocampus. Bioinformatic analyses suggested neurotransmitter/neurotrophic signaling, SNAp REceptor complex, and
glutamate receptor activity as common biological processes underlying the influence of antenatal maternal depressive
symptoms on fetal cortico-limbic development. These findings suggest gene–environment interdependence in the fetal
development of brain regions implicated in cognitive–emotional function. Candidate biological mechanisms involve a range
of brain region-specific signaling pathways that converge on common processes of synaptic development.
Key words: amygdala, cortical thickness, depression, morphological shape, polygenic risk score
Introduction
Antenatal maternal depression, independent of postnatal mater-
nal mood, influences fetal neurodevelopment, in particular the
amygdala, where alterations associate with affective disorders
(Rifkin-Graboi et al. 2013; Qiu et al. 2015a; Wen et al. 2017). Since
depression is a familial disorder with a significant estimate of
heritability (Sullivan et al. 2000), biological pathways linking
maternal mood during pregnancy to offspring neurodevelop-
ment are likely to vary as a function of genetic vulnerability for
depression. Studies of candidate genes or of family history sug-
gest the influence of “depressogenic” environmental conditions,
such as childhood maltreatment and socio-economic status
(SES), is moderated by genotype (Moffitt and Caspi 2006), reflect-
ing gene–environment interdependence. However, candidate
gene approaches bear weaknesses (Duncan and Keller 2011) and
gene products operate in networks, such that alterations in
neural systems that enhance vulnerability for psychopathology
derive from genomic variants at multiple sites and may converge
to influence common biological systems. Indeed, the genetic
contribution to susceptibility for depression appears to reflect
the cumulative influence of multiple genetic variants (Lubke
et al. 2012). This idea led to the use of methods of genomic risk
profiling to examine the influence of genetic burden as reflected
by a set of “risk” alleles for specific psychiatric disorders (Ripke
et al. 2013). The risk alleles and effect sizes of single-nucleotide
polymorphisms (SNPs) are established from existing genome-
wide association studies (GWAS) for depression using relevant
“discovery” samples based on their P-values below a defined
threshold. A genomic profile risk score (GPRS) is calculated for
each individual in the target sample as the sum of the count of
risk alleles weighted by the effect size in the discovery sample.
The GPRS for major depressive disorder (GPRSMDD) predicts the
risk for depression (P < 10−6) (Ripke et al. 2013) and moderates
the influence of childhood maltreatment on depressive symp-
toms (Peyrot et al. 2014). The target phenotype can also differ
from that examined in the discovery sample allowing cross-
phenotype analyses and studies of individual differences in
endophenotypes. For example, a higher GPRSMDD associates with
cortical thinning in the medial prefrontal cortex (Holmes et al.
2012), a region strongly implicated in the pathophysiology of
depression (Kupfer et al. 2012).
Given the evidence on the relationship between antenatal
maternal depression and the amygdala development during the
fetal period (Rifkin-Graboi et al. 2013; Qiu et al. 2015a), we exam-
inedwhether such relationshipwasmoderated by infant GPRSMDD,
controlling for maternal GPRSMDD using a longitudinal Asian birth
cohort sample. We then identified candidate genetic pathways
and biological processes thatmightmediate the influence of envir-
onment conditions associatedwith the genetic risk forMDD on the
amygdala. We repeated the analysis on the amygdala using a
US cohort of mother–infant dyads with measures of antenatal
maternal depressive symptoms, neonatal neuroimaging data, and
measures of GPRSMDD (see the description of the US cohort in the
Supplementary Material). In this study, we computed GPRSMDD
based on the SNPs selected from a Caucasian GWAS (Ripke et al.
2013). Given the fact on population differences in genotype fre-
quency and risk genetic variants for MDD (Woo et al. 2004; Serretti
et al. 2007; Porcelli et al. 2012; Sheikh et al. 2013; Ming et al. 2013,
2015), we noted that there may be a potential limitation of using a
Caucasian sample as a discovery sample for studying the GPRSMDD
in the Asian sample. Nevertheless, to the best of our knowledge,
the discovery sample used in this study is from one of the most
robust GWAS for MDD with the largest sample size (Ripke et al.
2013) at the current stage. Despite its limitation, it is informative in
the sense that individual SNPs have opposing effects between
Asian and Caucasian populations but they are still risk SNPs for
MDD. For instance, Caucasians with S allele of the serotonin trans-
porter polymorphism (5-HTTPLR) show higher amygdala activa-
tion in response to emotional stimuli (e.g., Hariri et al. 2002, 2005;
Murphy et al. 2013), whereas in Asians, L allele is associated with
amygdala hyperactivation (Li et al. 2012). Hence, we expected that
if Asian neonateswith high GPRSMDD show the positive association
between antenatal maternal depressive symptoms and the amyg-
dala volume, whereas Caucasian neonates with high GPRSMDD
show the opposite association or vice versa.
We further performed an exploratory analysis on whole brain
morphology, including cortical thickness and hippocampal
morphology, and examined whether GPRSMDD also modulates the
association of antenatal maternal depression and other brain
regions, particularly in the cortico-limbic system. Due to the com-
patibility in themagnetic resonance imaging (MRI) acquisition and
the anatomical definitions of the brain structures, this study only
performed the exploratory analysis using the Asian cohort. In par-
ticular, we employed large deformation diffeomorphic metric
mapping (LDDMM) (Du et al. 2011) to perform detailed analysis of
the morphological shape of cortical and subcortical brain regions.
This approach allows for precise anatomical examination of these
structures, well beyond that examined in brain volumetric studies,
and reveals specific-regional shape changes associated with dis-
ease status (Qiu et al. 2009, 2010). Based on genetic contribution to
MDD (Lubke et al. 2012) and the evidence that antenatal maternal
depression influences fetal cortico-limbic development (Qiu et al.
2015a), we hypothesized that neonates with high GPRSMDD may
show the negative relationship of antenatal maternal depression
with fetal development of the cortico-limbic structures, including
the hippocampus and prefrontal cortex. To further explore the
moderating influence of the GPRSMDD, we examined the effects of
SES, which influences the risk for a broad range of mental disor-
ders, including MDD (e.g., Gilman et al. 2003), and cortico-limbic
development (Farah et al. 2010; Noble et al. 2015).
This study, to the best of our knowledge, is the first kind to
provide a strategy for the analysis of gene–environment inter-
dependence and identify candidate biological processes that
might mediate the influence of antenatal maternal depressive
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symptoms on fetal brain development. Because of challenges
in imaging neonates shortly after birth, the sample size of this
study was modest for the study of gene–environment inter-
action and hence our findings are preliminary but may suggest
biologically plausible candidate processes for transgenerational
transmission of depression from mother to child.
Materials and Methods
Subjects
One-hundred and eighty-nine infants of mothers who partici-
pated in the prospective Growing Up in Singapore Towards
healthy Outcomes (GUSTO) birth cohort study (Soh et al. 2012)
were recruited for neuroimaging (Asian cohort). The Asian
cohort recruited pregnant women attending an antenatal ultra-
sound scan clinic who were Singapore citizens or Permanent
Residents of Chinese, Malay, or Indian ethnic background, and
had no history of psychotropic medication.
We included the 168 neonates with genetic and neuroimaging
data, gestational age at birth ≥35 weeks, birth weight >2500 g, and
a 5-min Appearance, Pulse, Grimace, Activity, and Respiration
score ≥9 and whose mothers had genetic data and returned the
questionnaires stated below. The Asian study was approved by
the National Healthcare Group Domain Specific Review Board
(NHG DSRB) and the Sing Health Centralized Institutional Review
Board (CIRB).Written consent was obtained frommothers.
Scales of Maternal Depressive Symptoms and SES
In GUSTO, the Edinburgh Postnatal Depression Scale (EPDS) ques-
tionnaire was administered to mothers at 26 weeks of pregnancy
to quantify depressive symptomatology. The EPDS (Cox et al. 1987)
is a widely used 10-item self-report scale designed as a screening
instrument for postnatal depression and valid for use in gestation.
Each item of the EPDS is scored on a 4-point scale (0–3), and items
3 and 5–10 are reverse scored. The reliability of the EPDS was 0.82
assessed using Cronbach’s analysis for our cohort. SES was mea-
sured using monthly household income (Table 1) and was col-
lected at 26 weeks gestation via questionnaire.
MRI Acquisition and Analysis
In the Asian cohort, axial fast spin-echo T2-weighted MRI (repeti-
tion time = 3500ms; echo time = 110ms; field of view = 256mm ×
256mm; matrix size = 256 × 256; 50 axial slices with 2.0mm thick-
ness) were acquired in infants 5–14 days of age using a 1.5-Tesla
general electric scanner at the Department of Diagnostic and
Interventional Imaging of the KK Women’s and Children’s
Hospital. The detailed acquisition and image quality check proced-
ure were previously reported (Qiu et al. 2013, 2015b). No sedation
was used and precautions taken to reduce exposure to the MRI
scanner noise. A neonatologist was present during scanning. A
pulse oximeter was used to monitor heart rate and oxygen satur-
ation throughout the entire scans. All brain scans were reviewed
by a neuroradiologist (M.V.F). To determine imagemotion, all axial
slices of the T2-weighted MRI data were visually inspected to
ensure no cross-slicemotion and checkerboard patterns.
Within individual subjects, when possible, 2 T2-weighted
MRI acquisitions were first rigidly aligned and averaged to
increase signal-to-noise ratio. In cases where only one scan
was acquired, data from one scan were used in lieu of the aver-
age axial image. The skull of the averaged axial image was
removed using Brain Extraction Tool (Smith 2002). A Markov
random field model was used to automatically delineate
amygdala, hippocampus, cortical gray matter, white matter,
and cerebrospinal fluid (CSF) from the neonatal T2-weighted
MRI data. The validation of this method in our sample was
reported elsewhere (Qiu et al. 2013, 2015b; Rifkin-Graboi et al.
2013). Against the manual segmentation of the 20 brain images
randomly selected in our data set, the segmentation accuracy
rates of the amygdala, hippocampus, cortical gray matter, and
white matter were respectively 0.75, 0.71, 0.79, and 0.86.
Based on the above tissue segmentation, a cortical surface
was constructed at the boundary between gray and white mat-
ter using a graph-based topology correction algorithm. Cortical
thickness was measured as the distance between cortical sur-
faces at the boundary between gray matter and CSF and at the
boundary of gray matter and white matter. We employed a
LDDMM algorithm to align individual cortical surfaces to the
Asian atlas that was generated based on the cortical anatomy
of the 20 subjects of this study and transferred the thickness of
each individual subject to the atlas (Bai et al. 2012). The cortical
thickness was smoothed using the Laplace–Beltrami basis func-
tions on the cortical surface (Qiu et al. 2006).
Amygdala and hippocampal morphological shapes were
represented using surfaces contoured at the structure boundary.
The LDDMM-surface mapping (Qiu and Miller 2008; Zhong and
Qiu 2010; Tan and Qiu 2016) was then used to take surfaces as
objects and provided transformation that deformed the Asian
atlas to be similar to subjects (Bai et al. 2012). Shape variations
of individual subjects relative to the Asian atlas were character-
ized by the Jacobian determinant of the transformation in the
logarithmic scale, which represents the ratio of structural vol-
ume to the atlas volume. Positive values correspond to expan-
sion, while negative values correspond to compression of the
structure relative to the atlas at each anatomical location.
SNP Genotyping and GPRS Computation for MDD
In the Asian cohort, genomic DNA was extracted from frozen
umbilical cord specimens for infants and from blood for mothers
according to standard procedures. The samples were genotyped
Table 1 Demographics of the Asian cohort
Mean SD
Gestational age (week) 38.69 1.13
Birth weight (gram) 3117.85 391.76
Birth weight adjusted by gestational age (gram) 3118.14 379.01
Postconceptual age at the MRI visit (week) 40.08 1.21
Antenatal maternal depression 8.59 4.46
N %
Sex, %
Male 168 53.6
Ethnicity, %
Chinese 168 44.0
Malay 39.3
Indian 16.7
Monthly household income (US$), %
≤768 168 3.0
769–1538 13.7
1538–3076 39.3
3077–4615 23.2
≥4616 13.7
Upreported 7.1
Note: SD, standard deviation.
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on Illumina Omni express arrays, shown to perform well and
with better coverage than alternatives in Asian populations
(Jiang et al. 2013), and on Illumina Exome arrays, following the
manufacturer’s instructions (Expression Analysis Inc). Further
quality control on the genotyping calls were previously described
(Qiu et al. 2015b). SNPs were verified for a genotyping rate ≥95%
and no deviation from Hardy–Weinberg equilibrium (P < 0.001),
and minor allele frequency ≥0.05, in PLINK (Purcell et al. 2007).
The GPRSMDD of infants and mothers was created using PLINK
based on their SNPs andmeta-analysis results from the Psychiatric
Genomics Consortium (PGC; European ancestry, 9240 MDD cases,
and 9519 controls) (Ripke et al. 2013). The GPRSMDD was a cumula-
tive summary score computed as the sum across SNPs of the num-
ber of risk alleles (0, 1, and 2) weighted by odd ratio. Odd ratios
were obtained from the meta-analysis on MDD from the
Psychiatric Genomics Consortium website (http://www.med.unc.
edu/pgc) (Ripke et al. 2013) and represented the allele-specific risk
for MDD. We selected the SNPs with low linkage disequilibrium to
each other (r2 < 0.25 within 500 kb window, filtering for signifi-
cance; PLINK-command -clump-p1 1 -clump-p2 1 -clump-r2 0.25
-clump-kb 500) (Peyrot et al. 2014) and that survived at P-value
thresholds (0.05, 0.1, and 0.2) to incorporate the proportion of vari-
ation in disease risk explained through their additive effects
(Purcell et al. 2009; Holmes et al. 2012; Peyrot et al. 2014). The result-
ing numbers of selected SNPs for infant GPRSMDD were 2766, 5081,
and 8935. The numbers of SNPs for maternal GPRSMDD were 2769,
5078, and 8902. This GPRSMDD was then standardized to a mean of
zero and standard deviation of one to aid interpretation of results.
Assume that genetic risks for rheumatoid arthritis (RA)
should not contribute to the risk for MDD and hence should not
modulate the relationship between maternal depressive symp-
toms and neonatal morphology. In this study, we computed
GPRS scores for RA (GPRSRA) as a negative control. We antici-
pated that GPRSRA would not modulate the relationship
between GPRSMDD and neonatal brain morphology.
Statistical Analysis
Linear regressions were used to examine interaction effects of
infant GPRSMDD with antenatal maternal depressive symptoms
(or SES) on amygdala and hippocampus volumes and shapes, as
well as cortical thickness of the whole brain in the Asian sample.
The EPDS scores (or SES) and the GPRSMDD of the infant were
included as main factors, which were entered into the first block
of linear regressions along with covariates of gender, maternal
ethnicity, birth weight adjusted by gestational age, postconcep-
tual age on the MRI day. The interaction of the 2 main factors
(EPDS score/SES and GPRSMDD) was then entered into the second
block of the regression. For statistical analysis on shapes and
thickness, the data were smoothed on the atlas surfaces using a
heat kernel with 30-mm full-width-at-half-maximum (Chung
et al. 2005). Statistical results were illustrated with P-value < 0.001
at the vertex level and with the cluster level of significance (P <
0.05) after correction for multiple comparisons based on random
field theory (Chung et al. 2005, 2010). The correction of multiple
comparisons was applied to one interaction model at a time, but
not across genomic polygenic risk scores (GPRSMDD and GPRSRA)
and different brain measures (volume, shape, and thickness).
If the interaction of the EPDS score (or SES) and GPRSMDD was
significant, we performed post hoc analyses where the sample
was then divided into 2 groups, one with a GPRSMDD greater
than its mean value, 0 (high GPRSMDD group) and the other ≥0
(low GPRSMDD group). We examined associations of antenatal
maternal depressive symptoms (or SES) and brain measures in
each GPRSMDD group using regression with EPDS (or SES) as a
main factor and covariates of gender, maternal ethnicity,
adjusted birth weight, and postconceptual age on the MRI day.
The brain measures used in this post hoc analysis were com-
puted as average values of thickness, or shape deformation of
the brain regions (colored regions shown in Fig. 2A and Fig. 3A)
with the significant interaction of GPRSMDD with antenatal
maternal depressive symptoms (or SES). The same analysis was
repeated while additionally controlling for maternal GPRSMDD.
For the interaction of GPRSMDD and antenatal maternal depres-
sive symptoms, the same analysis was also repeated while add-
itionally controlling for SES and vice versa.
Genetic Pathway Annotation Analysis
Genetic pathway enrichment was used to explore the underlying
biological processes associated with genes involved in the
GPRSMDD computation. We first selected the top SNPs that moder-
ated the relationship of antenatal maternal depressive symptoms
with individual brain regions. These SNPs were mapped to genes
using the batch query function in UCSC Genome Bioinformatics
(http://genome.ucsc.edu). PANTHER (http://pantherdb.org) was
then used to identify pathways that were statistically over-
represented against the reference genes involved in the same
genetic pathways based on fold enrichment analysis.
We further explored biological functions of each genetic path-
way using GeneMania (Mostafavi et al. 2008: http://Genemania.
org). GeneMania was developed as a heuristic algorithm, derived
from ridge regression, to integrate multiple functional association
networks and predict biological functions from a single process-
specific pathway. GeneMania was used to assess candidate bio-
logical functions associated with the genes in the pathways identi-
fied by PANTHER using multiple functional association data sets,
including co-expression analysis, protein–protein interactions, co-
localization, gene–gene interactions and protein domain similarity.
Results
Demographics
Table 1 and Supplementary Table S1 list the demographic infor-
mation of the Asian and US cohorts. In the Asian cohort, ante-
natal maternal depressive symptoms did not vary as a function
of infant gender (t166 = 0.11, P = 0.92) and ethnicity (F2165 = 2.26,
P = 0.11; Table 1). Antenatal maternal depressive symptoms did
not vary as a function of infant or maternal GPRSMDD based on
the 3 thresholds (all P > 0.2). But, SES was significantly corre-
lated with antenatal maternal depressive symptoms (r =
−0.273; P = 0.001) and significantly differed among the 3 mater-
nal ethnicity (F2155 = 4.726, P = 0.01).
Among 168 neonates, 85 had 1 good T2-weighted MRI scan
and 83 had 2 T2-weighted MRI scans. Between these 2 groups,
we did not observe differences in birth weight (t166 = −0.833, P =
0.406), postconceptual age on the MRI day (t166 = 0.180, P =
0.857), gender (χ = 1.908,12 P = 0.216), maternal ethnicity
(χ = 0.825,22 P = 0.662), and antenatal maternal depressive symp-
toms (t166 = 1.140, P = 0.256).
Interaction of GPRSMDD with Antenatal Maternal
Depressive Symptoms on Neonatal Brain Morphology
in the Asian cohort
Regression analysis revealed a significant interaction effect
between antenatal maternal depressive symptoms and infant
GPRSMDD on the right, but not left amygdala and hippocampal
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volumes (Table 2) after adjusting for gender, maternal ethnicity,
adjusted birth weight, and postconceptual age on the MRI day.
The interaction effect was apparent at all 3 threshold levels of
the GPRSMDD, with the largest interaction effect found using the
infant GPRSMDD at P = 0.2. These findings remained significant
when additionally controlling for the mother GPRSMDD (the
Supplementary Material; Table 2) and also the finding for the
right amygdala remained significant when additionally control-
ling for SES (the Supplementary Material). Subsequent post hoc
analysis revealed a significant positive association between ante-
natal maternal depressive symptoms and right hippocampal vol-
ume (t78 = 2.04, P = 0.045; Fig. 1B) and the marginal, positive
association between antenatal maternal depressive symptoms
and right amygdala volume (t78 = 1.80, P = 0.076; Fig. 1A) in neo-
nates with high GPRSMDD (>0). No associations were found
between antenatal maternal depressive symptoms and right
amygdala volume (t80 = −1.62, P = 0.109) and between antenatal
maternal depressive symptoms and right hippocampal volume
(t80 = −1.62, P = 0.109) in neonates with low GPRSMDD (<0).
Similarly, we found significant interaction effects between
infant GPRSMDD and antenatal maternal depressive symptoms on
the right amygdala shape (corrected cluster P = 7.86e-5; Fig. 2A) and
anterior right hippocampal shape (corrected cluster P = 0.016;
Fig. 2A), with the largest interaction effect at GPRSMDD of P = 0.2
among the 3 thresholds (0.05, 0.1, and 0.2). This interaction effect
was apparent for GPRSMDD of all 3 threshold levels. These findings
remained significant when controlling for maternal GPRSMDD and
the same finding on the right amygdala shape remained significant
when controlling for SES (the Supplementary Material). The post
hoc analysis revealed a significant positive association between
antenatal maternal depressive symptoms and right anterior hippo-
campal shape (t78 = 2.03, P = 0.046; Fig. 2C) and a marginal, positive
association between antenatal maternal depressive symptoms and
right amygdala shape (t78 = 1.84, P = 0.070; Fig. 2B) in neonates with
high infant GPRSMDD (>0). No associations were found between
antenatal maternal depressive symptoms and right amygdala
shape (t80 = −1.77, P = 0.08) and between antenatal maternal
depressive symptoms and right anterior hippocampal shape (t80 =
−1.63, P = 0.108) in neonateswith low infant GPRSMDD (<0).
We found a significant interaction effect between antenatal
maternal depressive symptoms and infant GPRSMDD on thickness
of left orbitofrontal cortex (OFC) and ventromedial prefrontal cor-
tex (vmPFC) (corrected cluster P = 0.031; Fig. 3A), with the largest
interaction effect using the GPRSMDD at P = 0.1 among the 3
thresholds (0.05, 0.1, and 0.2); the interaction was also apparent
using the GPRSMDD at P = 0.2. These findings remained significant
when additionally controlling for the maternal GPRSMDD (the
Supplementary Material). These findings became a trend of signifi-
cance after additionally controlling for SES (the Supplementary
Material). The post hoc analysis further revealed the significant
positive association between antenatal maternal depressive
symptoms and cortical thickness of left OFC and vmPFC (t85 =
2.63, P = 0.010) in neonates with high infant GPRSMDD (>0), sug-
gesting that a greater maternal depressive score was associated
with thicker cortex in left OFC and vmPFC (see Fig. 3B). No associ-
ation was found between antenatal maternal depressive symp-
toms and cortical thickness of left OFC and vmPFC (t80 = −0.054, P
= 0.957) in neonates with low infant GPRSMDD (<0).
In contrast to the GPRSMDD, GPRSRA did not moderate the
association of antenatal maternal depressive symptoms with
the right amygdala and hippocampus at all the 3 thresholds
(0.05, 0.1, and 0.2) of the GPRSRA computation (Table 3).
Moreover, the GPRSRA did not affect the association between
cortical thickness in the vmPFC and OFC and antenatal mater-
nal depressive symptoms (cluster P-value > 0.05).
Interaction of GPRSMDD with SES on Neonatal Brain
Morphology in the Asian Cohort
Likewise, a significant interaction effect between SES and infant
GPRSMDD on the right, but not left amygdala and hippocampal
Table 2 Statistical results for amygdala and hippocampal volumes
in the Asian sample
Structure Mean (SD) (mm3) Interaction effects
Left amygdala 211.41 (34.48) F1161 = 2.96, P = 0.087
Right amygdala 187.09 (33.77) F1161 = 6.88*
,a, P = 0.009
Left hippocampus 779.40 (108.18) F1161 = 0.002, P = 0.964
Right hippocampus 781.76 (109.11) F1161 = 4.15*
,a, P = 0.043
Note: F-values indicate the interaction effects of infant GPRSMDD with antenatal
maternal depressive symptoms on the structural volumes.
* P-value < 0.05.
aThe result remains significant when maternal GPRSMDD was entered in regres-
sion analysis as an additional covariate.
Figure 1. Interaction of the infant’s GPRSMDD with antenatal maternal depressive symptoms on the amygdala and hippocampal volumes. Scatter plots in panels (A)
and (B) illustrate the relationship of antenatal maternal depressive symptoms with right amygdala volume and right hippocampal volume in neonates with high
GPRS for major depressive disorder (GPRSMDD, blue asterisks) and those with low GPRSMDD (magenta circles).
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volumes and shapes (Supplementary Table S2) after adjusting for
gender, maternal ethnicity, adjusted birth weight, and postcon-
ceptual age on the MRI day. Such interaction effects remained sig-
nificant for the right hippocampus but not the right amygdala
when additionally controlling for antenatal maternal depressive
symptoms. No interaction effect between SES and infant
GPRSMDD was observed on cortical thickness.
Brain Region-Specific Gene Networks and Biological
Processes
Among the SNPs involved in the GPRSMDD, the top 1551 showed
the most significant interaction with antenatal maternal depres-
sive symptoms (P < 0.2) on the right amygdala, 1170 SNPs on the
right hippocampus, and 1236 SNPs on the left OFC and vmPFC
thickness, which were mapped to 629, 508, and 503 genes,
respectively. PANTHER analysis revealed biological pathways for
the 3 structures. These pathways were statistically over-
representative in relation to those in the PANTHER pathway
database (Table 4). For the right amygdala, 78 genes could not be
found in the PANTHER database. The remaining 551 genes
formed one statistically over-represented pathway (P = 0.003)
labeled by PANTHER as “metabotropic glutamate receptor group
III”. For the left OFC and vmPFC, 61 genes could not be found in
the PANTHER database. The remaining 442 genes formed 5 stat-
istically over-represented pathways, including “heterotrimeric
G-protein signaling pathway-Gq alpha and Go alpha” (P = 0.004),
“endothelin signaling” (P = 0.007), “histamine H1 receptor”
(P = 0.005), 5-HT2 type receptor (P = 0.013), and “oxytocin recep-
tor” (P = 0.044). For the right hippocampus, 69 genes could
not be found in the PANTHER database. The remaining
Table 3 Statistical results for amygdala and hippocampal volumes i-
n the Asian sample.
Threshold for the
GPRSRA computation
Right amygdala Right hippocampus
Antenatal maternal depression
P < 0.05 F1159 = 0.867, P = 0.353 F1159 = 1.457, P = 0.229
P < 0.1 F1159 = 1.662, P = 0.199 F1159 = 1.267, P = 0.262
P < 0.2 F1159 = 1.662, P = 0.199 F1159 = 1.267, P = 0.262
Note: F-values indicate the interaction effects of the infant’s GPRSRA with ante-
natal maternal depression on the structural volumes.
Figure 2. Statistical maps of the interaction effects of the infant GPRSMDD with antenatal maternal depressive symptoms (A) on the amygdala and hippocampal
shapes. Panels (B, C) illustrate the relationship of antenatal maternal depressive symptoms with right amygdala shape (left panel) and right hippocampal shape (right
panel) in neonates with high GPRS for major depressive disorder (GPRSMDD, blue astericks) and those with low GPRSMDD (magenta circles). Antenatal maternal depres-
sive symptoms are represented by the score of EPDS, with a higher score indicating more severe of depressive symptoms.
Figure 3. Statistical maps for interaction of the infant GPRSMDD with antenatal maternal depressive symptoms (A) on cortical thickness. Panel (B) illustrates the relation-
ship of antenatal maternal depressive symptoms with thickness of left OFC and vmPFC in neonates with high GPRSMDD, (blue asterisks) and those with low GPRSMDD
(magenta circles). Antenatal maternal depressive symptoms are represented by the score of EPDS, with a higher score indicating more severe of depressive symptoms.
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439 genes formed 2 statistically over-represented genetic path-
ways, including “axon guidance mediated by Slit/Robo” (P =
0.027) and “Alzheimer’s disease-amyloid secretase” (P = 0.047).
Supplementary Table S3 lists the genes involved in each
pathway.
The same analysis for SNPs in infant GPRSMDD that nominally
moderate the association between SES and fetal neurodevelop-
ment did not reveal any significantly enriched pathways for the
right amygdala. For the right hippocampus, 40 genes could not be
found in the PANTHER database and the remaining 311 genes
formed 4 statistically over-represented pathways (Table 4), includ-
ing “CCK receptor signaling” (P = 0.009), “Beta1” (P = 0.021) and
“Beta2 (P = 0.021) adrenergic receptor signaling”, and “5-HT2 type
receptor”mediated signaling pathways (P = 0.021). Supplementary
Table S4 lists the genes involved in each pathway.
We then entered the genes from the individual pathways
identified by PANTHER into GeneMania and identified candi-
date biological processes (Table 5). GeneMania identified
“Glutamate receptor activity” as the primary function of the
metabotropic glutamate receptor group III pathway, which
included genes that encode for subunits of the N-methyl-D-
aspartate (GRIN1, GRIN2A, GRIN2B, GRIN2C, and GRIN2D),
Kainate (GRK1-5), and α-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionic acid (GRIA1-4) receptors, as well as for the metabo-
tropic receptors (GRM1-8). This same pathway was also
significantly associated with the SNAp REceptor (SNARE) com-
plex function. Likewise, the SNARE complex emerged as the
primary biological function associated with both the 5-HT2-
type receptor- and the oxytocin receptor-mediated signaling
pathway identified as candidate moderators of the effect of
antenatal maternal depressive symptoms on cortical thickness
(Table 5).
The Findings from the US Cohort
We also examined the neonatal amygdala and hippocampus
structures using the US sample of 85 dyads with available neo-
natal brain imaging data of the amygdala and hippocampal
volumes, SNP data genotyped using the Illumina Omni express
arrays, and measures of maternal depressive symptoms
assessed using the Center for Epidemiologic Studies Depression
scale during the third trimester (the Supplementary Material).
We used the same statistical model as that employed with the
Asian cohort data and found a statistically significant interaction
effect between infant GPRSMDD and antenatal maternal depres-
sive symptoms on the right (F1,77 = 4.09, P = 0.047), but not left
amygdala volume (F1,77 = 1.21, P = 0.275), with the largest inter-
action effect at GPRSMDD of P = 0.1 among the 3 thresholds (0.05,
0.1, and 0.2). Interestingly, the US cohort showed the significant
positive association between antenatal maternal depressive
symptoms and right amygdala volume (t36 = 2.21, P = 0.034) in
neonates with low infant GPRSMDD (<0) and the marginal nega-
tive association between antenatal maternal depressive symp-
toms and right amygdala volume (t37 = −1.66, P = 0.105) in
neonates with high infant GPRSMDD (>0), which is opposite to
that seen in the Asian sample. This could be due to differences in
populations, which has been reported in other studies on Asian
and Caucasian populations based on individual SNPs (Sheikh
et al. 2013) (Woo et al. 2004; Serretti et al. 2007; Porcelli et al. 2012;
Ming et al. 2013, 2015). Nevertheless, interaction effects between
infant GPRSMDD and antenatal maternal depressive symptoms
were not observed on bilateral hippocampal volumes (left: F1,77 =
0.064, P = 0.801; right: F1,77 = 0.903, P = 0.345).
Among the SNPs involved in the GPRSMDD for the US sample,
the top 747 SNPs with the most significant interaction with
antenatal maternal depressive symptoms (P < 0.1) on the right
amygdala volume were mapped to 594 genes. For the right
amygdala, 65 genes could not be found in the PANTHER data-
base. The remaining 529 genes formed 2 statistically over-
represented pathway labeled by PANTHER as “metabotropic
glutamate receptor group III” (P = 0.002) and “metabotropic glu-
tamate receptor group I” (P = 0.003). Thus, despite the differ-
ences in sample size and ethnicity, these biological pathways
were strikingly similar to those identified in the Asian cohort
for the interaction between antenatal maternal depressive
symptoms and GPRSMDD on the right amygdala volume.
Discussion
This study provides evidence for the role of infant genotype as
a moderator of the association of antenatal maternal mental
health with fetal development of cortico-limbic structures,
Table 4 Genetic pathways associated with interaction of GPRSMDD and antenatal maternal depressive symptoms in the Asian sample
Structure Genetic pathways Fold enrichment P-valuea
Interaction of GPRSMDD and antenatal maternal depression
Right amygdala Metabotropic glutamate receptor group III >5 0.003
Left OFC and vmPFC Heterotrimeric G-protein signaling pathway-Gq alpha
and Go alpha mediated pathway
>5 0.004
Histamine H1 receptor-mediated signaling >5 0.005
Endothelin signaling >5 0.007
5-HT2 type receptor-mediated signaling >5 0.013
Oxytocin receptor-mediated signaling >5 0.044
Right hippocampus Axon guidance mediated by Slit/Robo >5 0.027
Alzheimer’s disease-amyloid secretase >5 0.047
Interaction of GPRSMDD and SES
Right hippocampus CCKR signaling map 4.36 0.009
5-HT2 type receptor medicated signaling pathway >5 0.021
Beta1 adrenergic receptor signaling pathway >5 0.021
Beta2 adrenergic receptor signaling pathway >5 0.021
Notes: The Fold Enrichment is defined as the ratio of the proportion of our input genes involved in a particular genetic pathway to the proportion of the reference
genes involved in the same genetic pathway.
aBonferroni corrected P-value.
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including structures such as the amygdala, hippocampus, OFC,
and vmPFC that are implicated in affective disorders. These
interaction effects were apparent using measures of depressive
symptoms across a community sample and remained signifi-
cant even after controlling for maternal GPRSMDD thus revealing
selective moderation by infant genotype. This study further
revealed over-representative genetic pathways and biological
processes formed by the genes included in the GPRSMDD com-
putation for which variations best contributed to modulating
the relationship of antenatal maternal depressive symptoms
and the morphology of the aforementioned brain structures.
The amygdala, hippocampus, OFC, and vmPFC are cortico-
limbic structures implicated in mood disorders and central to
emotion and social regulation. Abnormal morphology and
activity in these regions are reported in children (Thomas et al.
2001; Pagliaccio et al. 2014) and adults with MDD (Johnstone
et al. 2007). Smaller hippocampal volume and greater activity in
response to sad faces predict increased depressive symptoms
in children (Suzuki et al. 2013). In depressed children severity
correlates with activity of the amygdala–hippocampal complex
and medial PFC during sad mood elaboration (Pagliaccio et al.
2012) and amygdala reactivity during emotional face viewing
(Gaffrey et al. 2011). Likewise, children with early-life stress
show smaller OFC (Hanson et al. 2010). Children of parents
with MDD also show altered amygdala activity in the emotional
facial expression (Monk et al. 2008). Increased amygdala activa-
tion in response to novelty or threatening faces in children is
associated with measures of negative emotionality (Perez-
Edgar et al. 2007), which in turn predicts a greater risk for mood
disorders (Bruder-Costello et al. 2007). Moreover, altered func-
tional connectivity between the amygdala and medial PFC,
including OFC and vmPFC, is observed in 6-month-old infants
born to mothers with increased antenatal maternal depressive
symptoms (Qiu et al. 2015a). These findings suggest that the
cortico-limbic systems may be particularly vulnerable to mater-
nal influences during fetal development and reflect, in part, the
neural basis for the familial transmission of phenotypes asso-
ciated with depression.
Our study revealed an interaction effect between maternal
depressive symptoms and infant GPRSMDD that was apparent in
the right amygdala and hippocampus. Individual differences in
stress reactivity associate with morphology and function of the
prefrontal cortex, the hippocampus and the amygdala, as well
as the connections between these regions (Pruessner et al.
2008; van Marle et al. 2009) and there is compelling evidence
implicating the right hemisphere, notably the right amygdala
and right hippocampus in the regulation of stress responses
(Abercrombie et al. 1998; Carrion et al. 2007; Hamilton and
Gotlib 2008). The risk for depression is linked to heightened
stress reactivity, which associates with a familial risk for
depression: individuals with increased genetic vulnerability for
depression show greater negative affect in response to daily life
stress, which then predicts depression (Wichers et al. 2009).
Our findings suggest the familial transmission of individual dif-
ferences in neural systems that underlie stress reactivity may
occur during fetal development.
We explored gene networks and their associated biological
processes as candidate mediators of the influence of clinically
relevant environmental conditions on fetal neurodevelopment.
The gene pathways (metabotropic glutamate receptor group
pathways) derived from SNPs that best mediated the interaction
of antenatal maternal depressive symptoms and infant GPRSMDD
on the right amygdala in both the Asian and US cohorts were
strongly associated with glutamate receptor activity. Multiple
approaches, including genome-wide analyses, implicate gluta-
matergic synaptic transmission in the etiology of depression
(Skolnick et al. 2009; Lee et al. 2012) and patients with MDD
exhibit abnormal glutamate concentrations in the amygdala
(Michael et al. 2003). Postmortem studies with MDD suggest
altered glutamatergic synaptic signaling (Hashimoto et al. 2007)
and ketamine, a glutamatergic intervention, is a treatment for
MDD (Caddy et al. 2014). The antidepressant, tianeptine, blocks
stress-induced increases in glutamate release in the amygdala
(Piroli et al. 2013) and moderates behavioral responses to stress.
This glutamate receptor activity included the GRM1 and GRM8
genes, which are nominally associated with MDD (Terracciano
et al. 2010). Knockout mouse models of genes coding for metabo-
tropic glutamate receptor proteins, which modulate postsynaptic
glutamate signaling, associate with increased anxiety (Bures
et al. 2005). The “G-protein signaling” network also identified as a
candidate mediator for the effects of maternal depression on cor-
tical structure (Supplementary Table S3) includes the GRM1,
GRM4, GRM 7, and GRM8 genes.
The genetic pathway analysis in the right amygdala identi-
fied the “SNARE complex” biological process, which is a funda-
mental component of neural connectivity and neurotransmitter
release comprised of syntaxin, SNAP-25, and VAMP. Indeed, per-
haps the most compelling finding from our analysis was the
broad implication of the SNARE complex as a biological process
mediating the impact of antenatal maternal depressive symp-
toms on multiple brain structures (Table 5). Postmortem studies
revealed abnormal expression of SNARE proteins in the hippo-
campus and frontal cortex of subjects with MDD (Scarr et al.
2006). Likewise, proteomic analyses implicate synaptic
Table 5 Biological functions of genetic pathway in the Asian sample
Genetic pathway Biological function FDR corrected P-value Coverage
Metabotropic glutamate receptor group III Glutamate receptor activity 7.3e–46 20/20
SNARE complex 3.2e–18 12/32
G-protein signaling G-protein coupled receptor signaling 1.2e–32 29/125
Histamine H1 receptor-mediated signaling Inositol phosphate metabolic process 6.0e–19 13/55
Endothelin signaling Fibroblast growth factor signaling 1.5e–43 35/170
5-HT2 type receptor-mediated signaling SNARE complex 3.1e–25 15/32
Oxytocin receptor-mediated signaling SNARE complex 5.0e–26 15/32
Axon guidance mediated by Slit/Robo Small GTPase mediated signal transduction 3.9e–8 12/291
Amyloid secretase Neurotrophic signaling 2.4e–20 23/277
Beta1 adrenergic receptor signaling SNARE complex 1.6e–27 15/32
Beta2 adrenergic receptor signaling SNARE complex 1.6e–27 15/32
CCKR signaling Intracellular ligand-gated calcium channel activity 3.1e–14 7/10
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dysfunction in MDD and identify altered expression of SNARE
complex proteins (Martins-de-Souza et al. 2012). Administration
of ketamine as well as a broad range of antidepressant medica-
tions alters the accumulation of SNARE complexes in synaptic
membranes (Bonanno et al. 2005), which then associates with
altered capacity for stimulated glutamate release (Bonanno
et al. 2005). Two SNP’s (rs3787283 and rs3746544) in the SNAP-25
gene have been associated with MDD in a Han Chinese sample
(Wang et al. 2015), an ethnic group that accounted for the
majority of the Asian subjects in our study.
Our findings suggest that the influence of antenatal maternal
depressive symptoms on the cortico-limbic structure is mediated
by brain-specific signaling pathways (oxytocin, 5-HT2, and gluta-
mate receptor pathways). These pathways are linked to pro-
cesses underlying synaptic development. In addition to
association with the glutamate receptor activity, the SNARE com-
plex was the top biological process for the oxytocin and 5-HT2
gene networks (Table 5). There is strong evidence for the import-
ance of serotonin, including 5-HT2 receptor activation, in peri-
natal brain structure (see Lesch and Waider 2012 for a review).
While oxytocin receptor activation is not extensively described in
terms of brain development, there is a period of transient neocor-
tical expression of oxytocin receptor binding in rodent brain that
suggests a developmental influence (Hammock and Levitt 2013).
Finally, our analyses identified neurotrophic signaling systems as
candidate mediators of the effects of antenatal maternal depres-
sion on hippocampus (Table 4). The Fibroblast growth factor sig-
naling system is particularly interesting to consider in light of the
findings with rodent models that early postnatal administration
of FGF2 decreases fear behavior in animals genetic predisposed
to increased expression of anxiety-like behaviors (Eren-Kocak
et al. 2011). Sustained FGF2 effects on genes expression included
targets involved in cell survival, an effect that is consistent with
the role for neurotrophic signaling pathways as a mediator of the
effects of antenatal maternal depression. Neurotrophic signaling
pathway was the top biological process emerging from the amyl-
oid secretase network and includes genes coding for proteins
that mediate the effects of brain-derived neurotrophic factor sig-
naling, implicated in the pathophysiology of MDD and associated
with the activation of inositol phosphate metabolism (Duman
and Voleti 2012), which was also a top biological process identi-
fied in our analysis. Taken together, our findings are consistent
with the hypothesis that environmental conditions that increase
the risk for MDD associate with alterations in mechanisms con-
trolling synaptic plasticity in cortico-limbic brain regions (Duman
and Aghajanian 2012).
Interestingly, the direction of the interaction between mater-
nal depressive symptoms and infant genotype on right amygdala
volume in the US sample is in the opposite direction to that
observed in the Asian sample. This is not surprising as there is
now considerable evidence for opposing effects of individual
SNPs between Asian and Caucasian populations. For instance,
Sheikh et al. 2013 found that during childhood Caucasian chil-
dren homozygous for the Catechol-O-methyltransferase (COMT)
val allele show higher levels of internalizing symptoms com-
pared to children with at least one copy of the COMT met allele.
In contrast, Baumann et al. 2013 found that in Asians homozyges
of the COMT met allele with adverse childhood experiences show
higher anxiety sensitivity. Similar findings are apparent in stud-
ies of the serotonin transporter polomorphism (5-HTTPLR). Ming
et al. 2015 report a replication of the well-established interaction
between the 5-HTTPLR and stressful life events on emotional
health in Han Chinese, the principal ethnic group in our Asian
sample. However, in this study it was the L and not the S allele
that conferred greater sensitivity to stress; studies with
Caucasian samples commonly report that the S allele confers
sensitivity to adversity. This study was also a replication of a
previous, similar finding with the 5-HTTPLR variant (Ming et al.
2013). Meta-analyses likewise reveal differential effects of 5-
HTTLPR on selective serotonin reuptake inhibitors efficacy
between Caucasians and Asians (Serretti et al. 2007; Porcelli et al.
2012). Importantly, functional MRI studies show a link between S
allele and higher amygdala activation in response to emotional
stimuli in Caucasians (e.g., Hariri et al. 2002, 2005; Murphy et al.
2013), whereas in Asians L allele is associated with amygdala
hyperactivation (Li et al. 2012). These findings imply that the
same risk allele may operate in the opposite fashion as a func-
tion of ethnic background. Allele frequency may be a factor. The
frequency of the L allele is much lower than that of S allele in
Chinese population and Japan populations, but higher in
Caucasians or African–Americans (Lesch et al. 1996; He et al. 2010).
Importantly, despite the directional difference, the pathway ana-
lyses revealed the same underlying biological processes for the
amygdala effect in both samples. Indeed, PANTHER identified the
same primary pathway for both samples using independent ana-
lyses. These findings are consistent with the studies noted above,
that reveal effects of polymorphisms in the same genetic regions,
consistent with common underlying biological processes, but with
polymorphisms operating in an ethnicity-specific manner.
The relationship between antenatal maternal depression
and children’s outcomes is often observed as a function of gen-
der. Recent evidence suggests that girls born to depressed
mothers may be more likely to exhibit increased cortisol
reactivity in childhood and subsequently altered amygdala–
prefrontal cortex activity in adolescence (Burghy et al. 2012).
Nevertheless, our study did not observe the gender effect,
which may partly because of the age of children in this study. It
remains possible that gender differences could be observable at
later stages in development.
This study is best considered as exploratory and intended to
provide a strategy for the analysis of gene–environment inter-
dependence and identify candidate biological processes that
might mediate the influence of environment conditions asso-
ciated with the risk for MDD on fetal brain development. While
preliminary, our findings do suggest biologically plausible candi-
date processes in two independent cohorts. While the neonatal
neuroimaging dataset in this study is highly unique in its timing
of acquisition and number of subjects, it is nevertheless a modest
sample size for genomic analyses. Due to the time limit for scan-
ning of neonates and brain immaturity, the neonatal brain MRI, in
general, has relatively low contrast between gray and white mat-
ter, which could be challenging for imaging and the brain segmen-
tation. The contrast between gray matter and white matter is
relatively clear on T2-weighted MRI at the neonatal stage but is
diminished around 4–9 months of age. We reported the brain seg-
mentation accuracy in the Materials and Methods section to indi-
cate our constraint with the neonatal brain images. An additional
limitation is the use of GWAS datasets derived from Caucasians
for the definition of a GPRS to study within an Asian sample.
While this is an important caveat, we note that the Wang et al.
(2015) study identified multiple SNPs in the SNAP-25 gene, which
is a member of the SNARE complex, in the pathophysiology of
MDD in Asian population. Moreover, our assessment of maternal
depressive symptoms was based on a common screening tool
intended to elicit a subjective report of emotional well-being, but
does not constitute clinical assessment. The brain variations in
the offspring are thus best considered as being associated with
self-reported depressive symptoms and not to clinical depression,
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per se. Furthermore, other factors, such as marital discord, pater-
nal mental illness, medication during pregnancy, maternal sub-
stance use, or breastfeeding, could also influence the fetal brain
development over and beyond antenatal maternal depression
since the brain develops rapidly in early life (Uematsu et al. 2012).
In our study, SES was highly correlated with antenatal maternal
depressive symptoms and both showed its interaction with
GPRSMDD and influence the right amygdala and hippocampus
(Supplementary Table S2 and Figures S1 and S2). After controlling
for each other, the interaction effect of antenatalmaternal depres-
sion and GPRSMDD was mainly shown on the right amygdala,
while the interaction effect of SES and GPRSMDD was mainly
shown on the right hippocampus (the Supplementary Material).
These findings suggested that environment conditions associated
with the risk for MDD interplay with genetic risks for MDD on fetal
brain development. Finally, comparing brain anatomical mea-
sures across different cohorts, particularly, on neonates, is chal-
lenging. This is partly because of different strength of the MRI
scanners and imaging acquisition protocols. More importantly,
the challenge also lies in the definition of the anatomy of individ-
ual brain structures. In this study, we obtained the comparable
volume measure for the amygdala from the two cohorts. Hence,
this study incorporated the amygdala findings from both cohorts
where we could be certain of comparable anatomical localization.
Furthermore, the US cohort was lack of maternal GPRSMDD infor-
mation and hence our reported results for the US cohort could not
count for the contribution of maternal GPRSMDD.
Conclusion
We present a hypothesis-generating approach to the study of
gene × environment interaction that uses GPRS together with
bioinformatic approaches to identify candidate biological pro-
cesses mediating the influence of environmental conditions on
brain development and function. This approach is considered
as hypothesis-generating. For example, in larger samples, with
sufficient statistical power, we predict that a multi-gene locus
score, reflecting polymorphisms in genes involved in the bio-
logical processes of glutamate receptor activity, SNARE com-
plex, 5-HT2 receptor signaling, should moderate brain region-
specific effects of “depressogenic” environmental conditions
during fetal development.
Supplementary Material
Supplementary data is available at Cerebral Cortex online.
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